Use the Search Fields to Find Information
Page 22 of 382
The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?
Please use this link to access this publication: https://www.sciencedirect.com/science/article/abs/pii/S0959804922017671 Abstract Background The use of medical cannabis has rapidly increased among cancer patients worldwide. Cannabis is often administered concomitantly
November 29, 2023
The Use of Cannabis for Medical Purposes in the Arab World
Abstract The legal landscape of cannabis (marijuana) has dramatically changed over the past few years in several countries worldwide. Many patients now have legal access
June 26, 2025
The use of cannabis for Hyperemesis Gravidarum (HG)
Abstract Background: Hyperemesis Gravidarum (HG) responds only partially to standard antiemetic medications. Cannabis has been known to possess antiemetic effects and there are several medicinal
November 10, 2021
The Use of Cannabis and Its Effects on Postpartum Depression
Abstract Cannabis use and depression management have been studied, with a preponderance of exacerbating effects, but there are few studies on postpartum depression (PPD). Depression
March 20, 2024
The Use of Cannabinoids in the Treatment of Peripheral Neuropathy and Neuropathic Pain: A Systematic Review
Please use this link to access this publication. Abstract Purpose Peripheral neuropathies are commonly occurring conditions that are chronic and debilitating for patients. Established nonsurgical
April 19, 2026
The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study
Abstract Background: Insomnia is a prevalent condition that presents itself at both the symptom and diagnostic levels. Although insomnia is one of the main reasons
March 29, 2024
The use of cannabinoids as anticancer agents
It is well-established that cannabinoids exert palliative effects on some cancer-associated symptoms. In addition evidences obtained during the last fifteen years support that these compounds
September 19, 2019
The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
This is the report of an open label clinical trial to evaluate the effects of nabilone, an endocannabinoid receptor agonist, on treatment-resistant nightmares in patients
May 26, 2021
The TRPV2 channel mediates Ca2+ influx and the Δ9-THC-dependent decrease in osmotic fragility in red blood cells
Abstract Water and ionic homeostasis of red blood cells (RBC) is regulated by various active and passive transport mechanisms in the RBC membrane, including channels
April 30, 2024
Page 22 of 382